Clinical Trial Update: Neoadjuvant Doxorubicin/Cyclophosphamide Followed by Docetaxel (AC-Doc) Versus Dose-Dense Doxorubicin and Docetaxel (ADoc) in Breast Cancer [Phase 3]

View source ↗

Summary

A Phase 3 neoadjuvant trial in primary breast cancer compared AC-Doc (doxorubicin/cyclophosphamide followed by docetaxel) with dose-dense doxorubicin and doceta…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• DOCETAXEL (DOCETAXEL)
• Doxorubicin (doxorubicin)

Snippet

Sponsor: GBG Forschungs GmbH | Conditions: Primary Breast Cancer | Phase 3 | Status: COMPLETED